Work

Customized cancer cell weapons: Using CRISPR Cas9 genetic engineering and human adipose-derived mesenchymal stem cells to overcome platinum-based chemotherapy resistance in OVCAR-3 human ovarian cancer cells

Year: 2023
Type: other
Language: English
Open Access status: closed
OpenAlex ID: W4366777570
Cites:
Cited by:
Related to: 10